To clarify methodological aspects of the meta-analysis evaluating cangrelor's efficacy and safety in critically ill patients undergoing PCI.
Key Findings:
Heterogeneity in dosing and timing does not undermine the validity of pooled estimates.
Crude event data was used for primary analysis, consistent with meta-analysis standards.
Exploratory analyses were clearly distinguished and did not influence primary conclusions.
Interpretation:
The methodological approach was appropriate given the limited and heterogeneous evidence in critically ill populations, ensuring transparent reporting and avoiding overinterpretation.
Limitations:
Limited number of randomized controlled trials in the field.
Inconsistent reporting of dosing and timing across studies.
Exploratory analyses based on small sample sizes.
Conclusion:
The authors maintain that their methodological approach aligns with established standards for meta-analysis, emphasizing the importance of transparency and cautious interpretation of findings.
Data presented at the American College of Cardiology 75th Annual Scientific Session linked pregnancy-associated SCAD to more severe presentation and higher in-hospital major adverse cardiovascular events.
